Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy.

By Y. Yu, D. Landsittel, Ling Jing, J. Nelson, Baoguo Ren, Lijun Liu, Courtney McDonald, R. Thomas, R. Dhir, S. Finkelstein and 3 more. Journal of Clinical Oncology, 2004

766 citations recorded by the source corpus.

Subfields: Oncology, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/8be3bd0e253d2a736b72002f40143dec896e862a

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Pulmonary and Respiratory Medicine

1. Arul M. Chinnaiyan
2. Mark A. Rubin

Citations in the corpus

• The Estrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer (2014, unknown): “2a ) 7,10-22 , 28-31 28-31 .”
• Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression. (2005, methodology): “…assembled from eight publicly available prostate cancer gene expression data sets (Dhanasekaran et al., 2001; Lapointe et al., 2004; LaTulippe et al., 2002; Luo et al., 2001, 2002b; Singh et al., 2002; Welsh et al., 2001; Yu et al., 2004), and each probe was mapped to Unigene Build #173 (Table S3).”
• ConsensusPathDB: toward a more complete picture of cell biology (2010, background): “(20) comparing prostate carcinoma against metastatic prostate cancer patients.”